What we do

Our mission is to create quality biologics with passion to improve the lives of patients.

Whether this is through developing our own novel biologics or biosimilars or the provision of world-class development and manufacturing solutions to partners.

Polpharma Biologics has two streams of business, the development, and partnerships of our own molecules and providing top-quality contract development and manufacturing solutions to the industry to advance their biological pipeline of biosimilars and novel biologics.

Both our business streams are focused on our ambition to get effective and safe medicines to patients, and we care as much about our partners molecules as we do our own. Work on both our own pipeline and those of our partners takes place at multiple international centers of excellence in Poland and the Netherlands.

Biologics portfolio & partnerships

Polpharma Biologics has its own pipeline of biosimilar and novel therapeutics for out-licensing.

We are focused on advancing and expanding our product portfolio to increase patient access to these much-needed therapies and are open to partnering with other organizations to co-develop or commercialize our biosimilars or novel therapeutics.

Contract development & manufacturing solutions

We have all the required capabilities to support academic, small biotech and large pharma's biologic development projects from early stage discovery through to commercial supply.

Our greatest strength is our integration, being able to support entire projects with greater efficiency and full control on quality and performance, from cell line, process and analytical development to full GMP manufacturing of drug substance and drug product, including sterile fill & finish. Our services are available for both mammalian and microbial expression systems.

Let’s collaborate and create quality biologics together.

Get in touch for more information.

We use cookies

Polpharma Biologics uses cookies and other similar technologies (hereinafter: cookies) on its webpages and mobile applications (hereinafter, jointly, Website). The user can manage cookies independently by changing the web browser settings. If you do not consent for your personal data to be collected via cookies, you should change your web browser settings or stop using the Website.

Using the Website without changing the web browser settings indicates your acceptance of the use of cookies by Polpharma. Acceptance of the web browser settings indicates your consent to profiling on the basis of the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect lawfulness of any processing activities carried out under consent before its withdrawal.

For more details see the Cookie Policy.